Figure 4: Working model.
The anti-αvβ3 antibody (LM609) engages tumor-associated macrophages to eliminate aggressive αvβ3+ cancer cells by triggering antibody-dependent cellular cytotoxicity (ADCC).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.